Vadimezan (AS-A404)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 02:12, 26 July 2023 by Warner-admin (talk | contribs) (Warner-admin moved page Vadimezan (ASA-404) to Vadimezan (AS-A404) without leaving a redirect)
Jump to navigation Jump to search

Mechanism of action

From the NCI Drug Dictionary: A fused tricyclic analogue of flavone acetic acid with potential antineoplastic activity. Vadimezan induces the cytokines tumor necrosis alpha (TNF-alpha), serotonin and nitric oxide, resulting in hemorrhagic necrosis and a decrease in angiogenesis. This agent also stimulates the anti-tumor activity of tumor-associated macrophages.

Also known as

  • Code names: AS-1404, AS-A404